Atwater Malick’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$636K Hold
26,265
0.14% 68
2026
Q1
$637K Buy
26,265
+1,363
+5% +$33.1K 0.17% 53
2025
Q4
$605K Buy
24,902
+5,399
+28% +$131K 0.17% 51
2025
Q3
$475K Buy
19,503
+3,717
+24% +$90.1K 0.14% 58
2025
Q2
$383K Buy
15,786
+1,863
+13% +$44.9K 0.12% 59
2025
Q1
$337K Buy
13,923
+2,973
+27% +$71.5K 0.11% 61
2024
Q4
$262K Hold
10,950
0.09% 65
2024
Q3
$267K Hold
10,950
0.09% 68
2024
Q2
$260K Hold
10,950
0.09% 67
2024
Q1
$261K Buy
10,950
+630
+6% +$15K 0.09% 70
2023
Q4
$247K Buy
10,320
+1,590
+18% +$37.1K 0.1% 65
2023
Q3
$202K Hold
8,730
0.09% 62
2023
Q2
$205K Buy
+8,730
New +$207K 0.09% 64

Other funds holding IBDS

Atwater Malick's IBDS Position: Q2 2026 in Review

Atwater Malick held its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) position steady in Q2 2026 at 26,265 shares worth $636K. The position accounts for 0.14% of the portfolio, ranked #68.

Atwater Malick first reported a position in IBDS in Q2 2023 and has held it in 13 quarters since. The position peaked at $637K in Q1 2026. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Atwater Malick held 26,265 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $636K as of Q2 2026.
  • Atwater Malick left its iShares iBonds Dec 2027 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.14% of Atwater Malick's portfolio in Q2 2026, its #68 holding.
  • Atwater Malick first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2023 and has held it in 13 quarters since.
  • Atwater Malick's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $637K in Q1 2026.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Atwater Malick's 13F filing for Q2 2026, filed 27 Jul 2026.